US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

LMP Capital and Income Fund Inc

15.72

-0.0300-0.19%

Volume:37.88K

Turnover:593.77K

Market Cap:269.98M

PE:3.09

High:15.75

Open:15.75

Low:15.63

Close:15.75

Loading ...

Overview Company News Filings

SeaStar Medical Expands QUELIMMUNE Adoption for Critically Ill Pediatric Patients with Acute Kidney Injury (AKI)

LMP Capital and Income Fund Inc. Releases Report on Distribution Sources

Firefly uncovers way of measuring SCD, MCI, dementia in Alzheimer’s patients

BEAM Up on FDA's Orphan Drug Status for Gene-Editing Therapy

Sun Pharma Halts SCD-044 Development After Phase 2 Trials Miss Primary Endpoints

MT Newswires Live

BRIEF-LMP Capital And Income Fund Inc Authorizes 1-For-3 Rights Offering

Lmp Capital and Income Fund Inc: Authorizes 1-for-3 Rights Offering

THOMSON REUTERS

LMP Capital and Income Fund Inc. Releases Latest Distribution Report

The 2 Smartest Beaten-Down Biotech Stocks to Buy on the Dip

Director Anthony Grillo Reports Acquisition of Common Shares in LMP Capital and Income Fund Inc

Press Release: BioLineRx Reports First Quarter 2025 Financial Results and Provides Corporate Update

1 Stock Down 97% That Could Double, According to Wall Street

Press Release: Emmaus Life Sciences Reports Quarterly Financial Results

Vertex Reports First Quarter 2025 Financial Results

SeaStar Medical Announces CEO Interview on Benzinga All Access to Occur Today at Approximately 10:50 am Eastern Time

Fulcrum Therapeutics to Host First Quarter 2025 Financial Results Conference Call and Webcast on Thursday, May 1, 2025, at 8:00 a.m. ET

Press Release: Emmaus Life Sciences Reports 2024 Financial Results

AB Science receives notice of allowance for Unites States patent covering masitinib until 2040 in the treatment of sickle cell disease

FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery

Is Vertex Pharmaceuticals Incorporated (VRTX) the Best Gene-Editing Stock to Buy?

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/SCD/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SCD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SCD\",,,,,undefined,":{"symbol":"SCD","market":"US","secType":"STK","nameCN":"LMP Capital and Income Fund Inc","latestPrice":15.72,"timestamp":1751987444571,"preClose":15.75,"halted":0,"volume":37881,"delay":0,"floatShares":0,"shares":17174598,"eps":5.087105,"marketStatus":"Trading","change":-0.03,"latestTime":"07-08 11:11:40 EDT","open":15.75,"high":15.75,"low":15.63,"amount":593768.0641815,"amplitude":0.007619,"askPrice":15.83,"askSize":200,"bidPrice":15.59,"bidSize":11,"shortable":3,"etf":0,"ttmEps":5.087105,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1752004800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":15.75,"dividendRate":0.087786,"postHourTrading":{"tag":"盘后","latestPrice":15.75,"preClose":15.75,"latestTime":"16:04 EDT","volume":91,"amount":1437.65,"timestamp":1751918654906},"volumeRatio":1.411767},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SCD\",,,,,undefined,":{"symbol":"SCD","floatShares":0,"roa":"1.31%","roe":"30.34%","lyrEps":5.087105,"volumeRatio":1.411767,"shares":17174598,"dividePrice":1.38,"high":15.75,"amplitude":0.007619,"preClose":15.75,"low":15.63,"week52Low":13.35,"pbRate":"0.85","psRate":"24.58","week52High":17.96,"institutionHeld":0.2296,"latestPrice":15.72,"committee":-0.895735,"eps":5.087105,"divideRate":0.087786,"volume":37881,"delay":0,"ttmEps":5.087105,"open":15.75,"prevYearClose":17.2,"prevWeekClose":15.97,"prevMonthClose":15.6,"prevQuarterClose":15.6,"fiveDayClose":15.6,"twentyDayClose":16.57,"sixtyDayClose":14.54},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SCD\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2549542821","title":"SeaStar Medical Expands QUELIMMUNE Adoption for Critically Ill Pediatric Patients with Acute Kidney Injury (AKI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2549542821","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549542821?lang=en_us&edition=fundamental","pubTime":"2025-07-08 20:05","pubTimestamp":1751976300,"startTime":"0","endTime":"0","summary":"Nationally Recognized Texas Children’s Hospital Adds First-In-Class Therapy as a Potential Life-Saving Treatment in Ultra-Rare Cases of Pediatric AKIDENVER, July  08, 2025  (GLOBE NEWSWIRE) -- SeaStar","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/08/3111708/0/en/SeaStar-Medical-Expands-QUELIMMUNE-Adoption-for-Critically-Ill-Pediatric-Patients-with-Acute-Kidney-Injury-AKI.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCD"],"gpt_icon":0},{"id":"2548006142","title":"LMP Capital and Income Fund Inc. Releases Report on Distribution Sources","url":"https://stock-news.laohu8.com/highlight/detail?id=2548006142","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548006142?lang=en_us&edition=fundamental","pubTime":"2025-07-01 20:01","pubTimestamp":1751371263,"startTime":"0","endTime":"0","summary":"LMP Capital and Income Fund Inc.  has announced the estimated sources of its distribution to be paid on July 1, 2025. For the June monthly distribution, per share allocation is $0.1200, with 2.89% from net investment income and 97.11% from net realized long-term capital gains. Year-to-date distribution per share is $0.6990, maintaining the same percentage allocations. The fund indicates that portions of the distribution may exceed income and capital gains, potentially constituting a return of capital. The Board of Directors reserves the right to modify the distribution policy as needed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LMP Capital and Income Fund Inc. published the original content used to generate this news brief via Bus","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nNDLbWh7Km:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCD"],"gpt_icon":0},{"id":"2544124783","title":"Firefly uncovers way of measuring SCD, MCI, dementia in Alzheimer’s patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2544124783","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544124783?lang=en_us&edition=fundamental","pubTime":"2025-06-20 19:50","pubTimestamp":1750420214,"startTime":"0","endTime":"0","summary":"Firefly Neuroscience (AIFF) highlighted a leap forward in Alzheimer’s research to distinguish between subjective cognitive decline, mild cognitive ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/firefly-uncovers-way-of-measuring-scd-mci-dementia-in-alzheimers-patients-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/firefly-uncovers-way-of-measuring-scd-mci-dementia-in-alzheimers-patients-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AIFF","SCD","BK4167","BK4134","MCI"],"gpt_icon":0},{"id":"2541737093","title":"BEAM Up on FDA's Orphan Drug Status for Gene-Editing Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2541737093","media":"Zacks","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541737093?lang=en_us&edition=fundamental","pubTime":"2025-06-04 22:58","pubTimestamp":1749049080,"startTime":"0","endTime":"0","summary":"Beam TherapeuticsBEAM announced that the FDA has granted an orphan drug designation to its investigational genome-editing candidate, BEAM-101, for the treatment of sickle cell disease , an inherited blood disorder.The FDA grants orphan drug designation to support the development of medicines for rare disorders that affect fewer than 200,000 people in the United States. The designation makes the sponsor eligible to receive seven years of market exclusivity following a potential approval, along with the exemption of FDA application fees and tax credits for qualified clinical studies.Shares of Beam Therapeutics were up 4.3% yesterday following the announcement of the news.However, the stock has plunged 32% so far this year compared with the industry’s decline of 2.9%.In December 2024, the company announced new safety and efficacy data from the BEACON study evaluating BEAM-101 in SCD patients with severe vaso-occlusive crises.The data showed that treatment with BEAM-101 led to a robust and","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/beam-fdas-orphan-drug-status-145800778.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B894F039.SGD","LU0079474960.USD","LU0320765992.SGD","LU0058720904.USD","BK4505","LU2362541513.USD","SCD","LU2362541273.HKD","VRTX","LU2462157665.USD","BK4533","LU2237438978.USD","BK4567","LU1778281490.HKD","LU0417517546.SGD","LU1093756325.SGD","BEAM","IE00B19Z9P08.USD","LU1861558580.USD","LU2456880835.USD","SG9999001176.USD","LU2324357040.USD","IE0002270589.USD","BK4588","BK4611","LU1035775433.USD","BK4139","LU1093756168.USD","IE00BZ9MQY76.HKD","LU0234570918.USD","IE00BJJMRZ35.SGD","SG9999013999.USD","CRSP","SGXZ57979304.SGD","IE00B2B36J28.USD","LU0061475181.USD","BK4535","IE00BFTCPJ56.SGD","LU0889565916.HKD","IE0009355771.USD","LU1430594728.SGD","LU2236285917.USD","NTLA","LU0109394709.USD","IE00B19Z3B42.SGD","SG9999001176.SGD","LU2362540622.SGD","IE00B19Z3581.USD","LU1585245621.USD","BK4585"],"gpt_icon":0},{"id":"2540088221","title":"Sun Pharma Halts SCD-044 Development After Phase 2 Trials Miss Primary Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2540088221","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540088221?lang=en_us&edition=fundamental","pubTime":"2025-06-04 07:22","pubTimestamp":1748992931,"startTime":"0","endTime":"0","summary":"Sun Pharmaceutical Industries  reported Phase 2 trial results for SCD-044 in moderate to severe psoriasis and atopic dermatitis, according to a Tuesday filing on the local bourse.Neither trial met the primary endpoint of 75% improvement by Week 16.No major safety concerns were observed. The company is discontinuing SCD-044's development and will consider next steps with its partner.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SCD"],"gpt_icon":0},{"id":"2540321798","title":"BRIEF-LMP Capital And Income Fund Inc Authorizes 1-For-3 Rights Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2540321798","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540321798?lang=en_us&edition=fundamental","pubTime":"2025-06-02 20:16","pubTimestamp":1748866592,"startTime":"0","endTime":"0","summary":"BRIEF-LMP Capital And Income Fund Inc Authorizes 1-For-3 Rights OfferingJune 2 (Reuters) - LMP Capital And Income Fund Inc SCD.N:LMP CAPITAL AND INCOME FUND INC: AUTHORIZES 1-FOR-3 RIGHTS OFFERINGSource text: ID:nBw1TrlDCaFurther company coverage: SCD.N ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nFWN3S30DP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCD"],"gpt_icon":0},{"id":"2540176024","title":"Lmp Capital and Income Fund Inc: Authorizes 1-for-3 Rights Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2540176024","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540176024?lang=en_us&edition=fundamental","pubTime":"2025-06-02 20:03","pubTimestamp":1748865830,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nFWN3S30DP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SCD"],"gpt_icon":0},{"id":"2540760282","title":"LMP Capital and Income Fund Inc. Releases Latest Distribution Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2540760282","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540760282?lang=en_us&edition=fundamental","pubTime":"2025-06-02 20:00","pubTimestamp":1748865639,"startTime":"0","endTime":"0","summary":"LMP Capital and Income Fund Inc.  has announced its estimated sources of distribution for the upcoming payment on June 2, 2025. The distribution per share is set at $0.1200, with 5.22% sourced from net investment income and 94.78% from net realized long-term capital gains. No percentage of the distribution is attributed to net realized short-term capital gains or return of capital. For the fiscal year-to-date, the cumulative distribution per share is $0.5790, maintaining the same allocation percentages. Shareholders are advised that the distribution may include a return of capital. More information can be found on the fund's website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LMP Capital and Income Fund Inc. published the original ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nNDL3KPBxY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCD"],"gpt_icon":0},{"id":"2540760986","title":"The 2 Smartest Beaten-Down Biotech Stocks to Buy on the Dip","url":"https://stock-news.laohu8.com/highlight/detail?id=2540760986","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540760986?lang=en_us&edition=fundamental","pubTime":"2025-06-02 19:45","pubTimestamp":1748864700,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics has the potential to generate significant breakthroughs in gene editing.Regeneron's biggest growth driver is still performing well, and it is developing newer medicines.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/06/02/the-2-smartest-beaten-down-biotech-stocks-to-buy-o/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU0354030438.USD","LU0823434740.USD","CRSP","IE00BWXC8680.SGD","IE00B1XK9C88.USD","LU1674673428.USD","IE00BZ1G4Q59.USD","LU1989772923.USD","BK4588","LU1778281490.HKD","LU1069344957.HKD","SG9999001440.SGD","LU1496350502.SGD","BK4611","LU1861558580.USD","LU1093756325.SGD","LU1162221912.USD","BK4581","LU0868494708.USD","LU1551013425.SGD","LU1551013342.USD","LU0234572021.USD","LU0354030511.USD","LU0823434583.USD","LU0079474960.USD","BK4567","BK4504","IE00BSNM7G36.USD","BK4083","LU0820561909.HKD","LU0868494617.USD","SCD","BK4534","LU0820562030.AUD","LU1496350171.SGD","LU2756315664.SGD","LU0320765646.SGD","LU1989772840.SGD","LU2756315318.SGD","BK4566","BK4533","LU0943347566.SGD","LU1861559042.SGD","BK4585","LU1674673691.USD","LU0689472784.USD","LU0823411888.USD","BK4556","HD","BK4139"],"gpt_icon":0},{"id":"2539401083","title":"Director Anthony Grillo Reports Acquisition of Common Shares in LMP Capital and Income Fund Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2539401083","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539401083?lang=en_us&edition=fundamental","pubTime":"2025-05-29 05:05","pubTimestamp":1748466307,"startTime":"0","endTime":"0","summary":"Anthony Grillo, a Director, reported an acquisition of common shares of LMP Capital and Income Fund Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LMP Capital and Income Fund Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 28, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250528:nNDL3K6MC9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Director Anthony Grillo Reports Acquisition of Common Shares in LMP Capital and Income Fund Inc","news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCD"],"gpt_icon":0},{"id":"2538468287","title":"Press Release: BioLineRx Reports First Quarter 2025 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2538468287","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538468287?lang=en_us&edition=fundamental","pubTime":"2025-05-27 19:00","pubTimestamp":1748343600,"startTime":"0","endTime":"0","summary":"- New data from pilot phase of ongoing CheMo4METPANC Phase 2b combination trial of motixafortide in PDAC, sponsored by Columbia University, to be presented at upcoming 2025 ASCO Annual Meeting --. - APHEXDA performing well under Ayrmid stewardship -. - Management to host conference call today, May 27 , at 8:30 am EDT -. TEL AVIV, Israel, May 27, 2025 /PRNewswire/ -- BioLineRx Ltd.  , a development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today reported its unaudited financial results for the quarter ended March 31, 2025, and provided a corporate update.\"Following our announcement last November that we out-licensed APHEXDA, our FDA-approved stem cell mobilization agent, to Ayrmid Ltd., we have been actively evaluating new assets in the areas of oncology and rare disease where we can leverage our drug development and regulatory expertise to bring new medicines to market,\" said Philip Serlin, Chief Executive Officer of BioLineRx. \"I r","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFS","SCD","R","BK4195","BLRX","BK4139","BK4232","BK4022","BK4211"],"gpt_icon":0},{"id":"2538114699","title":"1 Stock Down 97% That Could Double, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2538114699","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538114699?lang=en_us&edition=fundamental","pubTime":"2025-05-25 18:00","pubTimestamp":1748167200,"startTime":"0","endTime":"0","summary":"The struggling biotech recently gave up on its leading pipeline candidate.Even if it matches Wall Street's estimates in the next year, the stock is too risky.Over the past few years, investors have moved away from somewhat speculative and unprofitable companies to put their money into safer, steadier investments. Editas Medicine , a gene-editing-focused clinical-stage biotech, is firmly in the speculative camp, which is why its shares are down by 97% since early 2021.The stock is trading for about $1.50 right now. However, its average price target of $3.38 (according to Yahoo!Finance) implies a potential upside of about 125%. Should investors scoop up the company's shares expecting them to soar?Editas Medicine has decided to pivot toward developing in vivo gene-editing therapies. Unlike the ex vivo variety, these kinds are administered via injection into the body of therapeutic genes -- so there is no need to collect the patients' cells. Editas Medicine has partners for some of its in ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/05/25/1-stock-down-97-could-double-according-to-wall-st/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["SCD"],"gpt_icon":0},{"id":"2535480892","title":"Press Release: Emmaus Life Sciences Reports Quarterly Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2535480892","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535480892?lang=en_us&edition=fundamental","pubTime":"2025-05-16 04:30","pubTimestamp":1747341000,"startTime":"0","endTime":"0","summary":"TORRANCE, Calif., May 15, 2025 /PRNewswire/ -- Emmaus Life Sciences, Inc. , a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its financial condition and results of operations as of and for the three months ended March 31, 2025.Net Revenues. Net revenues for the three months ended March 31, 2025 were $2.4 million, compared to $2.5 million in the same period in 2024.  The slight decrease was due to a decrease in U.S. sales which management attributes to competition from the generic version of L-Glutamine introduced in the market in mid-2024.Operating Expenses. Total operating expenses for the three months were $3.2 million compared to $5.0 million in the comparable period in 2024. The decrease was due primarily to decreases in selling expenses and general and administrative expenses attributable to a reduction in force in Q4 2024.Loss From Operations. We realized markedly improved loss from operations for the three months ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","SCD","EMMA","BK4007","BK4232","R"],"gpt_icon":0},{"id":"2533568415","title":"Vertex Reports First Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2533568415","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533568415?lang=en_us&edition=fundamental","pubTime":"2025-05-06 04:01","pubTimestamp":1746475260,"startTime":"0","endTime":"0","summary":"— Total revenue of $2.77 billion, a 3% increase compared to Q1 2024; raised the low end of total revenue guidance by $100 million to a new range of $11.85 to $12 billion —。— Strong progress with CASGEVY, ALYFTREK and JOURNAVX launches —。— Povetacicept  IgAN Phase 3 interim analysis  cohort fully enrolled and zimislecel Phase 3 program to complete dosing this quarter, setting up potential filings in 2026; inaxaplin Phase 3 IA cohort on track to complete enrollment in the second half of 2025 —。— Four programs already in pivotal development, with pivotal study of pove in primary membranous nephropathy  to start this year —。Combined GAAP and Non-GAAP R&D, Acquired IPR&D and SG&A expenses were $1.4 billion and $1.2 billion, respectively, compared to $1.2 billion and $1.0 billion, respectively, in the first quarter of 2024. The increases were primarily due to continued R&D investment in support of multiple mid- and late-stage clinical development programs and increased commercial investment ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vertex-reports-first-quarter-2025-200100412.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0289739699.SGD","IE00B19Z9Z06.USD","VTNR","BK4567","CHMP","LU1093756325.SGD","LU2237438978.USD","LU2362541513.USD","VRTX","LU1559883803.SGD","IE00BFTCPJ56.SGD","UAE","LU0234570918.USD","BK4585","LU1093756168.USD","LU0061475181.USD","BK4139","BK4588","IE0002270589.USD","IE00B894F039.SGD","IE00BJJMRZ35.SGD","LU0320765992.SGD","LU1815336091.USD","SCD","KSA","IE00B4R5TH58.HKD","CF","PBM","BK4138","LU1430594728.SGD","SGXZ57979304.SGD","IE00BJT1NW94.SGD","BK4533","IE0009355771.USD","LU0109394709.USD","BK4087","LU0889565916.HKD","LU1035775433.USD","LU2324357040.USD","IE00B19Z3581.USD","BK4532","IE0002141913.USD","VERX","SG9999001176.USD","SG9999013999.USD","BK4093","SG9999001176.SGD","LU2456880835.USD"],"gpt_icon":0},{"id":"2531031765","title":"SeaStar Medical Announces CEO Interview on Benzinga All Access to Occur Today at Approximately 10:50 am Eastern Time","url":"https://stock-news.laohu8.com/highlight/detail?id=2531031765","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531031765?lang=en_us&edition=fundamental","pubTime":"2025-04-30 20:05","pubTimestamp":1746014700,"startTime":"0","endTime":"0","summary":"DENVER, April 30, 2025  -- SeaStar Medical Holding Corporation , a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life announced today that Eric Schlorff, CEO of SeaStar Medical, will be a featured guest today, Wednesday, April 30th, at approximately 10:50 am Eastern Time on the Benzinga All Access Show.feature=share. An archived recording of the presentation will be available on the investor relations section of the Sea Star Medical’s website on the Events and Presentations page.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/seastar-medical-announces-ceo-interview-120500310.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ICUCW","SCD","ICU","BK4161","EML"],"gpt_icon":0},{"id":"2529866519","title":"Fulcrum Therapeutics to Host First Quarter 2025 Financial Results Conference Call and Webcast on Thursday, May 1, 2025, at 8:00 a.m. ET","url":"https://stock-news.laohu8.com/highlight/detail?id=2529866519","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529866519?lang=en_us&edition=fundamental","pubTime":"2025-04-24 20:00","pubTimestamp":1745496000,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., April 24, 2025  -- Fulcrum Therapeutics, Inc.  , a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that its first quarter 2025 financial results will be released on Thursday, May 1, 2025, before the U.S. financial markets open. Management will host a conference call and webcast at 8:00 a.m. ET to discuss the results and provide an update on recent corporate developments.Individuals may register for the conference call by clicking the link here. Once registered, participants will receive dial-in details and unique PIN which will allow them to access the call. An audio webcast will be accessible through the Investor Relations section of the company’s website at www.fulcrumtx.com or by clicking here. Following the live webcast, an archived replay will also be available.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fulcrum-therapeutics-host-first-quarter-120000118.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","BK4181","BK4588","HST","BK4561","FULC","BK4590","BK4581","ET","BK4585","BK4144","BK4218","SCD"],"gpt_icon":0},{"id":"2527414125","title":"Press Release: Emmaus Life Sciences Reports 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2527414125","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527414125?lang=en_us&edition=fundamental","pubTime":"2025-04-15 06:25","pubTimestamp":1744669500,"startTime":"0","endTime":"0","summary":"TORRANCE, Calif., April 14, 2025 /PRNewswire/ -- Emmaus Life Sciences, Inc. , a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its financial condition and results of operations as of and for the year ended December 31, 2024.Other Expense. The company incurred other expense of $4.5 million for the year compared to $7.3 million in 2023. The decrease was due primarily to an increase of $1.0 million in gain on restructured debt and decreases of $1.9 million in interest expenses, $1.7 million in net loss on equity method investment and $1.6 million in foreign exchange loss, partially offset by a $2.5 million change in fair value of conversion feature derivative liability and $1.1 million in change in fair value of warrant derivat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","EMMA","BK4022","BK4007","BK4232","SCD"],"gpt_icon":0},{"id":"2527190412","title":"AB Science receives notice of allowance for Unites States patent covering masitinib until 2040 in the treatment of sickle cell disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2527190412","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527190412?lang=en_us&edition=fundamental","pubTime":"2025-04-15 00:02","pubTimestamp":1744646520,"startTime":"0","endTime":"0","summary":"AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR UNITED STATES PATENT COVERING MASITINIB UNTIL 2040 IN THE TREATMENT OF SICKLE CELL DISEASE. AB Science SA  today announced that the United States Patent Office has issued a Notice of Allowance for a patent relating to methods of treating sickle cell disease  with its lead compound masitinib, based on preclinical data. This new US patent provides intellectual property protection for masitinib in this indication until November 2040 and further strengthens masitinib’s intellectual property, following a notice of allowance received from the European Patent Office in October 2024 for the same patent.Masitinib clinical development in SCD is being conducted as part of the SICKMAST collaborative program, funded with 9.2 million euros [3], which aims to demonstrate in a phase 2 clinical trial the efficacy of masitinib in the treatment of acute and chronic complications of SCD in patients identified based on biomarkers. The Assistance Publique-Hpitaux ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ab-science-receives-notice-allowance-160200174.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4213","BK4135","LU0128526141.USD","BK4598","IE00BLDYK493.USD","VOC","IE00B64QTZ34.USD","BK4007","LU0029874061.USD","ABSCF","BK4590","SCD","AB","RBC","BK4161","LU2065731478.USD"],"gpt_icon":0},{"id":"2525089154","title":"FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery","url":"https://stock-news.laohu8.com/highlight/detail?id=2525089154","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525089154?lang=en_us&edition=fundamental","pubTime":"2025-04-08 20:05","pubTimestamp":1744113900,"startTime":"0","endTime":"0","summary":"DENVER, April 08, 2025  -- SeaStar Medical Holding Corporation , a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced today that the U.S. Food and Drug Administration  has granted SeaStar Medical two new Breakthrough Device Designations for its Selective Cytopheretic Device  therapy. The two new Breakthrough Device Designations are indicated for the treatment of systemic inflammatory response in 1) adult patients undergoing cardiac surgery and 2) pediatric patients undergoing cardiac surgery towards prevention of post-operative adverse complications and outcomes. Approximately 15 percent of the estimated 300,000 adults that undergo cardiac surgery each year are considered high risk and, we believe, could benefit most from the SCD therapy to prevent post-surgical complications. Of the 40,000 pediatric patients that undergo congenital heart surgery each year, we believe that approxi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fda-grants-seastar-medical-two-120500036.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","ICU","ICUCW","BK4212","BK4585","CPB","BK4082","SCD"],"gpt_icon":0},{"id":"2524144944","title":"Is Vertex Pharmaceuticals Incorporated (VRTX) the Best Gene-Editing Stock to Buy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2524144944","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524144944?lang=en_us&edition=fundamental","pubTime":"2025-04-02 00:42","pubTimestamp":1743525776,"startTime":"0","endTime":"0","summary":"We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated  stands against other best gene-editing stocks to buy.Gene editing is an advanced medical technique within gene therapy that involves precisely modifying an individual’s DNA to treat or prevent diseases. This approach directly alters genetic material to correct mutations, enhance cellular functions, or eliminate disease-causing genes. Industry experts believe that gene editing has the potential to revolutionize the treatment of genetic disorders, cancers, and various other conditions.The number of patients receiving gene therapies is expected to fluctuate over the next decade. In 2020, 16,244 patients were treated, with this figure projected to rise to 94,696 by 2025 before gradually declining to 65,612 by 2034 as existing patient stocks deplete. Over the next decade, an estimated 1.09 million patients could benefit from gene thera","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vertex-pharmaceuticals-incorporated-vrtx-best-164256812.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BFTCPJ56.SGD","SCD","LU0109394709.USD","IE00BJT1NW94.SGD","LU0566484027.USD","LU2362541513.USD","IE00B19Z3B42.SGD","LU2417539215.USD","USJW.SI","LU2456880835.USD","LU0256863811.USD","QLD",".IXIC","TSYW.SI","USAW.SI","NVIW.SI","MNQmain","IE0009355771.USD","BK4588","LU0757428866.USD","VERX","BK4585","IE0002141913.USD","LU0889565916.HKD","NQmain","TQQQ","LU0289739699.SGD","PSQ","LU0061475181.USD","LU0234570918.USD","LU0320765992.SGD","LU1585245621.USD","LU2236285917.USD","BK4532","LU2362540622.SGD","VRTX","BK4023","IE00BJJMRZ35.SGD","SQQQ","IE00B19Z9Z06.USD","LU2324357040.USD","LU2362541273.HKD","LU2462157665.USD","LU0058720904.USD","BK4139","BK4567","QID","IE00B19Z9P08.USD","IE00B4R5TH58.HKD"],"gpt_icon":1}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":53,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SCD\",params:#limit:5,,,undefined,":[{"date":"2025-08-22","symbol":"SCD","amount":0.12,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-08-22","defaultRemindTime":1755869400000,"name":"LMP Capital & Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-02","payableDate":"2025-08-22","currency":"USD","dateTimestamp":1755835200000,"payDate":"2025-09-02"},{"date":"2025-06-23","symbol":"SCD","amount":0.12,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"LMP Capital & Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-07-01"},{"market":"US","date":"2025-06-12","symbol":"SCD","firstDealingDate":"2025-06-12","lastDealingDate":"2025-07-11","announcementDate":"2025-06-02","defaultRemindTime":1749735000000,"recordDate":"2025-06-12","rightsSymbol":"SCD.RTWI","type":"rights","dateTimestamp":1749700800000},{"date":"2025-05-22","symbol":"SCD","amount":0.12,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-22","defaultRemindTime":1747920600000,"name":"LMP Capital & Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-02","payableDate":"2025-05-22","currency":"USD","dateTimestamp":1747886400000,"payDate":"2025-06-02"},{"date":"2025-04-23","symbol":"SCD","amount":0.12,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-23","defaultRemindTime":1745415000000,"name":"LMP Capital & Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-01","payableDate":"2025-04-23","currency":"USD","dateTimestamp":1745380800000,"payDate":"2025-05-01"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SCD\",market:\"US\",,,undefined,":[{"executeDate":"2015-09-16","recordDate":"2015-09-18","paymentDate":"2015-09-25","value":0.28,"currency":"USD"},{"executeDate":"2015-12-16","recordDate":"2015-12-18","paymentDate":"2015-12-24","value":0.31,"currency":"USD"},{"executeDate":"2016-03-16","recordDate":"2016-03-18","paymentDate":"2016-03-24","value":0.31,"currency":"USD"},{"executeDate":"2016-06-15","recordDate":"2016-06-17","paymentDate":"2016-06-24","value":0.31,"currency":"USD"},{"executeDate":"2016-09-21","recordDate":"2016-09-23","paymentDate":"2016-09-30","value":0.31,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SCD\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SCD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SCD","date":"2025-07-03","current":3.145051,"percent":0.760691,"low":-75.230419,"twenty":-11.623592,"median":2.603727,"eighty":3.866076,"high":10.684334,"avg":-8.331602,"sd":21.995566,"marketCap":274278330},"quantilePoints":[{"date":"2020-07-10","current":3.839938,"twenty":2.516908,"median":10.990385,"eighty":89.994993,"marketCap":179653466},{"date":"2020-07-17","current":3.920658,"twenty":2.516908,"median":10.990385,"eighty":89.994993,"marketCap":183429966},{"date":"2020-07-24","current":3.897595,"twenty":2.516908,"median":10.990385,"eighty":89.994993,"marketCap":182350966},{"date":"2020-07-31","current":-9.700105,"twenty":-3.511994,"median":10.946787,"eighty":89.994993,"marketCap":183429966},{"date":"2020-08-07","current":-9.985402,"twenty":-3.719344,"median":10.880056,"eighty":89.994993,"marketCap":188824965},{"date":"2020-08-14","current":-10.270699,"twenty":-3.767089,"median":10.848066,"eighty":89.994993,"marketCap":194219964},{"date":"2020-08-21","current":-10.318249,"twenty":-3.830522,"median":10.768359,"eighty":89.994993,"marketCap":195119130},{"date":"2020-08-28","current":-10.451388,"twenty":-3.868036,"median":10.752318,"eighty":89.994993,"marketCap":197636796},{"date":"2020-09-04","current":-10.318249,"twenty":-4.055681,"median":10.728255,"eighty":89.994993,"marketCap":195119130},{"date":"2020-09-11","current":-9.933573,"twenty":-4.079554,"median":10.70419,"eighty":89.994993,"marketCap":187844873},{"date":"2020-09-18","current":-10.26119,"twenty":-4.112976,"median":10.680128,"eighty":89.994993,"marketCap":194040130},{"date":"2020-09-25","current":-9.519417,"twenty":-4.124571,"median":10.648043,"eighty":89.994993,"marketCap":180013133},{"date":"2020-10-02","current":-9.852264,"twenty":-4.151855,"median":10.619969,"eighty":89.994993,"marketCap":186307298},{"date":"2020-10-09","current":-10.090011,"twenty":-4.18937,"median":10.591895,"eighty":89.994993,"marketCap":190803131},{"date":"2020-10-16","current":-10.023442,"twenty":-4.220745,"median":10.563821,"eighty":89.994993,"marketCap":189544298},{"date":"2020-10-23","current":-9.918833,"twenty":-4.267127,"median":10.531737,"eighty":89.994993,"marketCap":187566131},{"date":"2020-10-30","current":-9.22461,"twenty":-4.276786,"median":10.503663,"eighty":89.994993,"marketCap":174438301},{"date":"2020-11-06","current":-9.937853,"twenty":-4.294411,"median":10.48361,"eighty":89.994993,"marketCap":187925798},{"date":"2020-11-13","current":-10.280209,"twenty":-4.304642,"median":10.451525,"eighty":89.994993,"marketCap":194399797},{"date":"2020-11-20","current":-10.527467,"twenty":-4.318284,"median":10.41543,"eighty":89.994993,"marketCap":199075463},{"date":"2020-11-27","current":-10.831784,"twenty":-4.331244,"median":10.367304,"eighty":89.994993,"marketCap":204830128},{"date":"2020-12-04","current":-11.25022,"twenty":-4.348296,"median":10.307145,"eighty":89.994993,"marketCap":212742793},{"date":"2020-12-11","current":-11.117081,"twenty":-4.366712,"median":10.267039,"eighty":89.994993,"marketCap":210225127},{"date":"2020-12-18","current":-11.449928,"twenty":-4.408319,"median":10.218913,"eighty":89.994993,"marketCap":216519293},{"date":"2020-12-24","current":-11.012472,"twenty":-4.478574,"median":10.178807,"eighty":89.994993,"marketCap":208246961},{"date":"2020-12-31","current":-11.079042,"twenty":-4.492898,"median":10.158755,"eighty":89.994993,"marketCap":209505794},{"date":"2021-01-08","current":-11.098061,"twenty":-4.537915,"median":10.102607,"eighty":89.994993,"marketCap":209865461},{"date":"2021-01-15","current":-11.26924,"twenty":-4.592892,"median":9.9863,"eighty":89.994993,"marketCap":213102460},{"date":"2021-01-22","current":-11.25973,"twenty":-4.634772,"median":9.882025,"eighty":89.994993,"marketCap":212922627},{"date":"2021-01-29","current":-9.384477,"twenty":-5.012694,"median":8.507985,"eighty":89.994993,"marketCap":209865461},{"date":"2021-02-05","current":-9.673973,"twenty":-5.126545,"median":8.507985,"eighty":89.994993,"marketCap":216339459},{"date":"2021-02-12","current":-9.875011,"twenty":-5.23389,"median":8.507985,"eighty":89.994993,"marketCap":220835292},{"date":"2021-02-19","current":-9.899136,"twenty":-5.250154,"median":8.507985,"eighty":89.994993,"marketCap":221374792},{"date":"2021-02-26","current":-9.794596,"twenty":-5.267249,"median":8.507985,"eighty":89.994993,"marketCap":219036959},{"date":"2021-03-05","current":-9.887121,"twenty":-5.287562,"median":8.507985,"eighty":90.097979,"marketCap":221106101},{"date":"2021-03-12","current":-10.256583,"twenty":-5.303827,"median":8.507985,"eighty":90.097979,"marketCap":229368393},{"date":"2021-03-19","current":-10.192329,"twenty":-5.324157,"median":8.507985,"eighty":90.097979,"marketCap":227931473},{"date":"2021-03-26","current":-10.06382,"twenty":-5.337169,"median":8.507985,"eighty":89.994993,"marketCap":225057632},{"date":"2021-04-01","current":-10.272646,"twenty":-5.356686,"median":8.507985,"eighty":89.994993,"marketCap":229727623},{"date":"2021-04-09","current":-10.505568,"twenty":-5.387589,"median":8.507985,"eighty":90.097979,"marketCap":234936459},{"date":"2021-04-16","current":-10.690299,"twenty":-5.391655,"median":8.507985,"eighty":90.097979,"marketCap":239067604},{"date":"2021-04-23","current":-10.674235,"twenty":-5.414425,"median":8.507985,"eighty":90.097979,"marketCap":238708374},{"date":"2021-04-30","current":-10.794712,"twenty":-5.459966,"median":8.507985,"eighty":90.097979,"marketCap":241402600},{"date":"2021-05-07","current":-10.931252,"twenty":-5.477043,"median":8.507985,"eighty":90.097979,"marketCap":244456055},{"date":"2021-05-14","current":-10.794712,"twenty":-5.499813,"median":8.507985,"eighty":90.097979,"marketCap":241402600},{"date":"2021-05-21","current":-11.027634,"twenty":-5.52177,"median":8.507985,"eighty":90.097979,"marketCap":246611436},{"date":"2021-05-28","current":-11.308746,"twenty":-5.539661,"median":8.507985,"eighty":90.097979,"marketCap":252897962},{"date":"2021-06-04","current":-11.549699,"twenty":-5.555112,"median":8.507985,"eighty":90.097979,"marketCap":258286413},{"date":"2021-06-11","current":-11.935225,"twenty":-5.57463,"median":8.507985,"eighty":90.097979,"marketCap":266907934},{"date":"2021-06-18","current":-11.493477,"twenty":-5.582762,"median":8.507985,"eighty":90.097979,"marketCap":257029107},{"date":"2021-06-25","current":-11.477413,"twenty":-5.590894,"median":8.507985,"eighty":90.097979,"marketCap":256669877},{"date":"2021-07-02","current":-11.738446,"twenty":-5.608785,"median":8.507985,"eighty":90.097979,"marketCap":262507366},{"date":"2021-07-09","current":-11.68624,"twenty":-5.619357,"median":8.507985,"eighty":90.097979,"marketCap":261339868},{"date":"2021-07-16","current":-11.405127,"twenty":-5.629115,"median":8.507985,"eighty":90.097979,"marketCap":255053342},{"date":"2021-07-23","current":-11.501509,"twenty":-5.673826,"median":8.507985,"eighty":90.097979,"marketCap":257208722},{"date":"2021-07-30","current":2.940516,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":256131032},{"date":"2021-08-06","current":2.946703,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":256669877},{"date":"2021-08-13","current":2.992068,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":260621408},{"date":"2021-08-20","current":2.901337,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":252718347},{"date":"2021-08-27","current":3.008565,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":262058328},{"date":"2021-09-03","current":3.045682,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":265291399},{"date":"2021-09-10","current":2.997966,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":261135107},{"date":"2021-09-17","current":2.946703,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":256669877},{"date":"2021-09-24","current":2.86422,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":249485276},{"date":"2021-10-01","current":2.855971,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":248766816},{"date":"2021-10-08","current":2.901337,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":252718347},{"date":"2021-10-15","current":2.963199,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":258106798},{"date":"2021-10-22","current":3.035372,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":264393324},{"date":"2021-10-29","current":3.039496,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":264752554},{"date":"2021-11-05","current":3.066303,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":267087549},{"date":"2021-11-12","current":3.082799,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":268524469},{"date":"2021-11-19","current":3.041558,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":264932169},{"date":"2021-11-26","current":2.98382,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":259902948},{"date":"2021-12-03","current":2.897213,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":252359117},{"date":"2021-12-10","current":2.992068,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":260621408},{"date":"2021-12-17","current":2.981758,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":259723333},{"date":"2021-12-23","current":3.004441,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":261699098},{"date":"2021-12-31","current":3.134351,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":273014845},{"date":"2022-01-07","current":3.084862,"twenty":-9.236022,"median":8.507985,"eighty":89.994993,"marketCap":268704084},{"date":"2022-01-14","current":3.047744,"twenty":-9.236022,"median":8.507985,"eighty":89.994993,"marketCap":265471014},{"date":"2022-01-21","current":2.876592,"twenty":-9.236022,"median":8.507985,"eighty":89.994993,"marketCap":250562966},{"date":"2022-01-28","current":2.907523,"twenty":-9.236022,"median":8.45586,"eighty":89.994993,"marketCap":253257192},{"date":"2022-02-04","current":3.014751,"twenty":-9.236022,"median":8.432693,"eighty":89.994993,"marketCap":262597173},{"date":"2022-02-11","current":2.942579,"twenty":-9.236022,"median":8.412422,"eighty":89.994993,"marketCap":256310647},{"date":"2022-02-18","current":2.921958,"twenty":-9.236022,"median":8.392152,"eighty":89.994993,"marketCap":254514497},{"date":"2022-02-25","current":2.913709,"twenty":-9.236022,"median":8.374777,"eighty":89.994993,"marketCap":253796037},{"date":"2022-03-04","current":2.882049,"twenty":-9.236022,"median":8.366089,"eighty":89.994993,"marketCap":251038288},{"date":"2022-03-11","current":2.817511,"twenty":-9.236022,"median":8.345818,"eighty":89.994993,"marketCap":245416717},{"date":"2022-03-18","current":2.914318,"twenty":-9.236022,"median":8.325547,"eighty":89.994993,"marketCap":253849074},{"date":"2022-03-25","current":2.884066,"twenty":-9.236022,"median":8.30238,"eighty":89.994993,"marketCap":251213963},{"date":"2022-04-01","current":2.972806,"twenty":-9.236022,"median":8.287901,"eighty":89.994993,"marketCap":258943623},{"date":"2022-04-08","current":2.884066,"twenty":-9.236022,"median":8.270526,"eighty":89.994993,"marketCap":251213963},{"date":"2022-04-14","current":2.851797,"twenty":-9.236022,"median":8.235776,"eighty":89.994993,"marketCap":248403177},{"date":"2022-04-22","current":2.851797,"twenty":-9.236022,"median":8.209598,"eighty":89.994993,"marketCap":248403177},{"date":"2022-04-29","current":2.682383,"twenty":-9.236022,"median":8.189443,"eighty":89.994993,"marketCap":233646553},{"date":"2022-05-06","current":2.734821,"twenty":-9.236022,"median":8.180755,"eighty":89.994993,"marketCap":238214079},{"date":"2022-05-13","current":2.625912,"twenty":-9.236022,"median":8.166276,"eighty":89.994993,"marketCap":228727678},{"date":"2022-05-20","current":2.60776,"twenty":-9.236022,"median":8.151797,"eighty":89.994993,"marketCap":227146611},{"date":"2022-05-27","current":2.797342,"twenty":-9.236022,"median":8.105463,"eighty":89.994993,"marketCap":243659976},{"date":"2022-06-03","current":2.823561,"twenty":-9.236022,"median":8.073609,"eighty":89.994993,"marketCap":245943740},{"date":"2022-06-10","current":2.732804,"twenty":-9.236022,"median":8.053338,"eighty":89.994993,"marketCap":238038405},{"date":"2022-06-17","current":2.404061,"twenty":-9.236022,"median":8.021484,"eighty":89.994993,"marketCap":209403527},{"date":"2022-06-24","current":2.500868,"twenty":-9.247434,"median":8.004109,"eighty":90.097979,"marketCap":217835884},{"date":"2022-07-01","current":2.517003,"twenty":-9.247434,"median":7.980942,"eighty":90.097979,"marketCap":219241276},{"date":"2022-07-08","current":2.537171,"twenty":-9.247434,"median":7.969359,"eighty":90.097979,"marketCap":220998017},{"date":"2022-07-15","current":2.535154,"twenty":-9.247434,"median":7.957775,"eighty":90.097979,"marketCap":220822343},{"date":"2022-07-22","current":2.595659,"twenty":-9.247434,"median":7.934609,"eighty":90.097979,"marketCap":226092566},{"date":"2022-07-29","current":2.704568,"twenty":-9.247434,"median":6.088551,"eighty":90.097979,"marketCap":235578968},{"date":"2022-08-05","current":2.688433,"twenty":-9.247434,"median":6.007831,"eighty":90.097979,"marketCap":234173575},{"date":"2022-08-12","current":2.785241,"twenty":-9.247434,"median":5.973237,"eighty":90.097979,"marketCap":242605932},{"date":"2022-08-19","current":2.785241,"twenty":-9.247434,"median":5.900205,"eighty":90.097979,"marketCap":242605932},{"date":"2022-08-26","current":2.696501,"twenty":-9.247434,"median":5.312107,"eighty":90.097979,"marketCap":234876271},{"date":"2022-09-02","current":2.573474,"twenty":-9.247434,"median":4.989229,"eighty":90.097979,"marketCap":224160151},{"date":"2022-09-09","current":2.654147,"twenty":-9.247434,"median":4.262754,"eighty":90.097979,"marketCap":231187115},{"date":"2022-09-16","current":2.573474,"twenty":-9.247434,"median":4.089784,"eighty":90.097979,"marketCap":224160151},{"date":"2022-09-23","current":2.31532,"twenty":-9.247434,"median":4.043659,"eighty":90.097979,"marketCap":201673866},{"date":"2022-09-30","current":2.272967,"twenty":-9.247434,"median":3.99369,"eighty":90.097979,"marketCap":197984710},{"date":"2022-10-07","current":2.291118,"twenty":-9.247434,"median":3.951408,"eighty":90.097979,"marketCap":199565777},{"date":"2022-10-14","current":2.268933,"twenty":-9.247434,"median":3.905283,"eighty":90.097979,"marketCap":197633362},{"date":"2022-10-21","current":2.333472,"twenty":-9.247434,"median":3.889907,"eighty":90.097979,"marketCap":203254933},{"date":"2022-10-28","current":2.450448,"twenty":-9.247434,"median":3.870689,"eighty":90.097979,"marketCap":213444031},{"date":"2022-11-04","current":2.429271,"twenty":-9.247434,"median":3.839938,"eighty":90.097979,"marketCap":211599453},{"date":"2022-11-11","current":2.581542,"twenty":-9.247434,"median":3.813032,"eighty":90.097979,"marketCap":224862848},{"date":"2022-11-18","current":2.559356,"twenty":-9.247434,"median":3.751531,"eighty":90.097979,"marketCap":222930432},{"date":"2022-11-25","current":2.597676,"twenty":-9.247434,"median":3.716937,"eighty":90.097979,"marketCap":226268240},{"date":"2022-12-02","current":2.585575,"twenty":-9.247434,"median":3.663124,"eighty":90.097979,"marketCap":225214196},{"date":"2022-12-09","current":2.4807,"twenty":-9.247434,"median":3.58671,"eighty":90.097979,"marketCap":216079143},{"date":"2022-12-16","current":2.460532,"twenty":-9.247434,"median":3.555498,"eighty":90.097979,"marketCap":214322402},{"date":"2022-12-23","current":2.381875,"twenty":-9.247434,"median":3.490154,"eighty":90.097979,"marketCap":207471112},{"date":"2022-12-30","current":2.428263,"twenty":-9.247434,"median":3.309496,"eighty":90.097979,"marketCap":211511616},{"date":"2023-01-06","current":2.420195,"twenty":-9.247434,"median":3.134351,"eighty":90.097979,"marketCap":210808920},{"date":"2023-01-13","current":2.537171,"twenty":-9.247434,"median":3.098088,"eighty":90.097979,"marketCap":220998017},{"date":"2023-01-20","current":2.484734,"twenty":-9.247434,"median":3.084862,"eighty":90.097979,"marketCap":216430491},{"date":"2023-01-27","current":2.535154,"twenty":-9.247434,"median":3.080737,"eighty":90.097979,"marketCap":220822343},{"date":"2023-02-03","current":-73.781452,"twenty":-9.441436,"median":3.070427,"eighty":90.097979,"marketCap":223633129},{"date":"2023-02-10","current":-73.607575,"twenty":-9.615782,"median":3.064241,"eighty":90.097979,"marketCap":223106107},{"date":"2023-02-17","current":-73.549616,"twenty":-9.666828,"median":3.055993,"eighty":90.097979,"marketCap":222930432},{"date":"2023-02-24","current":-71.289227,"twenty":-9.690595,"median":3.049806,"eighty":90.097979,"marketCap":216079143},{"date":"2023-03-03","current":-72.738194,"twenty":-9.745753,"median":3.04362,"eighty":90.097979,"marketCap":220470995},{"date":"2023-03-10","current":-69.376589,"twenty":-9.806616,"median":3.039496,"eighty":90.097979,"marketCap":210281897},{"date":"2023-03-17","current":-67.695786,"twenty":-9.852264,"median":3.025061,"eighty":90.097979,"marketCap":205187348},{"date":"2023-03-24","current":-66.826405,"twenty":-9.868605,"median":3.014751,"eighty":90.097979,"marketCap":202552237},{"date":"2023-03-31","current":-70.767598,"twenty":-9.889524,"median":3.009081,"eighty":89.994993,"marketCap":214498076},{"date":"2023-04-06","current":-69.666382,"twenty":-9.905569,"median":3.008565,"eighty":90.30395,"marketCap":211160268},{"date":"2023-04-19","current":-72.622277,"twenty":-9.923821,"median":3.000317,"eighty":90.612908,"marketCap":220119647},{"date":"2023-04-28","current":-70.477804,"twenty":-9.947385,"median":2.994306,"eighty":90.81888,"marketCap":213619705},{"date":"2023-05-05","current":-68.507208,"twenty":-9.985022,"median":2.990006,"eighty":90.81888,"marketCap":207646786},{"date":"2023-05-12","current":-69.724341,"twenty":-9.994912,"median":2.985882,"eighty":90.81888,"marketCap":211335942},{"date":"2023-05-19","current":-70.65168,"twenty":-10.046106,"median":2.981758,"eighty":90.81888,"marketCap":214146727},{"date":"2023-05-26","current":-69.492506,"twenty":-10.086379,"median":2.97351,"eighty":90.81888,"marketCap":210633245},{"date":"2023-06-02","current":-69.898217,"twenty":-10.114737,"median":2.967323,"eighty":90.81888,"marketCap":211862964},{"date":"2023-06-09","current":-71.984731,"twenty":-10.155699,"median":2.961137,"eighty":90.81888,"marketCap":218187232},{"date":"2023-06-16","current":-73.72813,"twenty":-10.198754,"median":2.952889,"eighty":90.81888,"marketCap":223471509},{"date":"2023-06-23","current":-72.04269,"twenty":-10.25168,"median":2.947653,"eighty":90.921866,"marketCap":218362906},{"date":"2023-06-30","current":-72.680236,"twenty":-10.270699,"median":2.944641,"eighty":90.951291,"marketCap":220295321},{"date":"2023-07-07","current":-71.694937,"twenty":-10.28097,"median":2.940516,"eighty":90.951291,"marketCap":217308861},{"date":"2023-07-14","current":-73.897369,"twenty":-10.318249,"median":2.932268,"eighty":90.951291,"marketCap":223984477},{"date":"2023-07-20","current":-74.882667,"twenty":-10.336901,"median":2.919896,"eighty":90.951291,"marketCap":226970937},{"date":"2023-07-28","current":-73.955328,"twenty":-10.373407,"median":2.915045,"eighty":90.097979,"marketCap":224160151},{"date":"2023-08-04","current":-21.900189,"twenty":-10.41739,"median":2.903399,"eighty":16.981542,"marketCap":223281781},{"date":"2023-08-11","current":-22.055265,"twenty":-10.473441,"median":2.901337,"eighty":16.844419,"marketCap":224862848},{"date":"2023-08-18","current":-22.072496,"twenty":-10.502916,"median":2.898184,"eighty":16.694236,"marketCap":225038522},{"date":"2023-08-25","current":-22.313725,"twenty":-10.566513,"median":2.891027,"eighty":16.544053,"marketCap":227497959},{"date":"2023-09-01","current":-22.882338,"twenty":-10.63247,"median":2.882837,"eighty":16.443931,"marketCap":233295204},{"date":"2023-09-08","current":-22.67557,"twenty":-10.683175,"median":2.880716,"eighty":16.319867,"marketCap":231187115},{"date":"2023-09-15","current":-22.244803,"twenty":-10.736884,"median":2.86422,"eighty":15.971617,"marketCap":226795263},{"date":"2023-09-22","current":-21.641729,"twenty":-10.809272,"median":2.8559,"eighty":15.823611,"marketCap":220646669},{"date":"2023-09-29","current":-21.15927,"twenty":-10.841294,"median":2.84978,"eighty":15.76702,"marketCap":215727794},{"date":"2023-10-06","current":-20.556197,"twenty":-10.858966,"median":2.844673,"eighty":15.730018,"marketCap":209579201},{"date":"2023-10-13","current":-21.176501,"twenty":-10.942973,"median":2.837413,"eighty":15.682134,"marketCap":215903468},{"date":"2023-10-20","current":-21.538345,"twenty":-11.00106,"median":2.831227,"eighty":15.636426,"marketCap":219592625},{"date":"2023-10-27","current":-19.901431,"twenty":-11.016276,"median":2.825578,"eighty":15.595072,"marketCap":202903585},{"date":"2023-11-03","current":-21.004194,"twenty":-11.082846,"median":2.817511,"eighty":15.534128,"marketCap":214146727},{"date":"2023-11-10","current":-20.590658,"twenty":-11.117081,"median":2.795325,"eighty":15.431829,"marketCap":209930549},{"date":"2023-11-17","current":-21.831267,"twenty":-11.164174,"median":2.785241,"eighty":15.34912,"marketCap":222579084},{"date":"2023-11-24","current":-22.244803,"twenty":-11.204054,"median":2.762048,"eighty":15.281647,"marketCap":226795263},{"date":"2023-12-01","current":-22.67557,"twenty":-11.254024,"median":2.732804,"eighty":15.148876,"marketCap":231187115},{"date":"2023-12-08","current":-22.589416,"twenty":-11.310355,"median":2.726754,"eighty":15.090109,"marketCap":230308745},{"date":"2023-12-15","current":-23.347566,"twenty":-11.356937,"median":2.704568,"eighty":15.022635,"marketCap":238038405},{"date":"2023-12-22","current":-23.881717,"twenty":-11.397096,"median":2.696501,"eighty":14.979104,"marketCap":243484302},{"date":"2023-12-29","current":-24.191869,"twenty":-11.411888,"median":2.69045,"eighty":14.913807,"marketCap":246646436},{"date":"2024-01-05","current":-23.881717,"twenty":-11.451962,"median":2.683391,"eighty":14.85504,"marketCap":243484302},{"date":"2024-01-12","current":-23.674949,"twenty":-11.477413,"median":2.65919,"eighty":14.800626,"marketCap":241376213},{"date":"2024-01-19","current":-23.45095,"twenty":-11.499903,"median":2.642046,"eighty":14.713563,"marketCap":239092450},{"date":"2024-01-26","current":-23.778333,"twenty":-11.543274,"median":2.622886,"eighty":14.58297,"marketCap":242430258},{"date":"2024-02-02","current":9.626529,"twenty":-11.568976,"median":2.616836,"eighty":14.349599,"marketCap":243659976},{"date":"2024-02-09","current":9.869448,"twenty":-11.568976,"median":2.616836,"eighty":9.657067,"marketCap":249808570},{"date":"2024-02-16","current":9.834745,"twenty":-11.568976,"median":2.616836,"eighty":9.657067,"marketCap":248930199},{"date":"2024-02-23","current":9.869448,"twenty":-11.568976,"median":2.616836,"eighty":9.657067,"marketCap":249808570},{"date":"2024-03-01","current":9.786162,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":247700481},{"date":"2024-03-08","current":9.756733,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":246955611},{"date":"2024-03-15","current":10.007253,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":253296595},{"date":"2024-03-22","current":10.183294,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":257752421},{"date":"2024-03-28","current":10.460897,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":264778917},{"date":"2024-04-05","current":10.257773,"twenty":-11.568976,"median":2.616836,"eighty":9.657067,"marketCap":259637579},{"date":"2024-04-12","current":10.176523,"twenty":-11.568976,"median":2.616836,"eighty":9.657067,"marketCap":257581043},{"date":"2024-04-19","current":9.763504,"twenty":-11.568976,"median":2.616836,"eighty":9.657067,"marketCap":247126989},{"date":"2024-04-26","current":10.14944,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":256895532},{"date":"2024-05-03","current":10.227304,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":258866378},{"date":"2024-05-10","current":10.413502,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":263579271},{"date":"2024-05-17","current":10.447356,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":264436161},{"date":"2024-05-24","current":10.217148,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":258609311},{"date":"2024-05-31","current":10.095274,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":255524508},{"date":"2024-06-07","current":10.406731,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":263407893},{"date":"2024-06-14","current":10.460897,"twenty":-11.568976,"median":2.616836,"eighty":9.657067,"marketCap":264778917},{"date":"2024-06-21","current":10.359335,"twenty":-11.575401,"median":2.613811,"eighty":9.637634,"marketCap":262208248},{"date":"2024-06-28","current":10.403684,"twenty":-11.588252,"median":2.609777,"eighty":9.622365,"marketCap":263330773},{"date":"2024-07-05","current":10.521834,"twenty":-11.588252,"median":2.609777,"eighty":9.622365,"marketCap":266321318},{"date":"2024-07-12","current":10.494751,"twenty":-11.588252,"median":2.609777,"eighty":9.622365,"marketCap":265635807},{"date":"2024-07-15","current":10.521834,"twenty":-11.588252,"median":2.609777,"eighty":9.622365,"marketCap":266321318},{"date":"2024-08-02","current":4.208455,"twenty":-11.59789,"median":2.60171,"eighty":5.980925,"marketCap":267178208},{"date":"2024-08-09","current":4.170663,"twenty":-11.59789,"median":2.60171,"eighty":5.938643,"marketCap":264778917},{"date":"2024-08-16","current":4.265144,"twenty":-11.59789,"median":2.60171,"eighty":5.362076,"marketCap":270777145},{"date":"2024-08-23","current":4.421713,"twenty":-11.59789,"median":2.60171,"eighty":5.046886,"marketCap":280717065},{"date":"2024-08-30","current":4.421713,"twenty":-11.59789,"median":2.60171,"eighty":4.421713,"marketCap":280717065},{"date":"2024-09-06","current":4.419013,"twenty":-11.59789,"median":2.60171,"eighty":4.408215,"marketCap":280545687},{"date":"2024-09-13","current":4.451407,"twenty":-11.59789,"median":2.60171,"eighty":4.402816,"marketCap":282602223},{"date":"2024-09-20","current":4.753746,"twenty":-11.59789,"median":2.60171,"eighty":4.402816,"marketCap":301796552},{"date":"2024-09-27","current":4.699757,"twenty":-11.59789,"median":2.60171,"eighty":4.402816,"marketCap":298368993},{"date":"2024-10-04","current":4.815833,"twenty":-11.59789,"median":2.60171,"eighty":4.402816,"marketCap":305738244},{"date":"2024-10-11","current":4.664664,"twenty":-11.59789,"median":2.60171,"eighty":4.402816,"marketCap":296141080},{"date":"2024-10-18","current":4.688959,"twenty":-11.59789,"median":2.60171,"eighty":4.402816,"marketCap":297683481},{"date":"2024-10-25","current":4.591778,"twenty":-11.59789,"median":2.60171,"eighty":4.402816,"marketCap":291513875},{"date":"2024-10-31","current":4.53509,"twenty":-11.59789,"median":2.60171,"eighty":4.402816,"marketCap":287914939},{"date":"2024-11-08","current":4.613374,"twenty":-11.604315,"median":2.599693,"eighty":4.38554,"marketCap":292884899},{"date":"2024-11-15","current":4.599877,"twenty":-11.604315,"median":2.599693,"eighty":4.38554,"marketCap":292028009},{"date":"2024-11-22","current":4.670063,"twenty":-11.604315,"median":2.599693,"eighty":4.38554,"marketCap":296483836},{"date":"2024-11-29","current":4.813134,"twenty":-11.604315,"median":2.599693,"eighty":4.38554,"marketCap":305566867},{"date":"2024-12-06","current":4.756445,"twenty":-11.604315,"median":2.599693,"eighty":4.38554,"marketCap":301967930},{"date":"2024-12-13","current":4.678161,"twenty":-11.604315,"median":2.599693,"eighty":4.38554,"marketCap":296997970},{"date":"2024-12-20","current":4.443308,"twenty":-11.604315,"median":2.599693,"eighty":4.38554,"marketCap":282088089},{"date":"2024-12-27","current":4.645768,"twenty":-11.604315,"median":2.599693,"eighty":4.38554,"marketCap":294941434},{"date":"2025-01-03","current":4.605276,"twenty":-11.604315,"median":2.599693,"eighty":4.38554,"marketCap":292370765},{"date":"2025-01-10","current":4.526991,"twenty":-11.610741,"median":2.597676,"eighty":4.379601,"marketCap":287400805},{"date":"2025-01-17","current":4.605276,"twenty":-11.610741,"median":2.597676,"eighty":4.379601,"marketCap":292370765},{"date":"2025-01-24","current":4.769943,"twenty":-11.610741,"median":2.597676,"eighty":4.379601,"marketCap":302824819},{"date":"2025-01-31","current":3.372162,"twenty":-11.610741,"median":2.597676,"eighty":4.349907,"marketCap":294084545},{"date":"2025-02-07","current":3.368232,"twenty":-11.610741,"median":2.597676,"eighty":4.270338,"marketCap":293741789},{"date":"2025-02-14","current":3.374127,"twenty":-11.610741,"median":2.597676,"eighty":4.219659,"marketCap":294255922},{"date":"2025-02-21","current":3.415395,"twenty":-11.610741,"median":2.597676,"eighty":4.178221,"marketCap":297854859},{"date":"2025-02-28","current":3.295129,"twenty":-11.610741,"median":2.597676,"eighty":4.101017,"marketCap":287366529},{"date":"2025-03-07","current":3.155998,"twenty":-11.617166,"median":2.597676,"eighty":4.050578,"marketCap":275232971},{"date":"2025-03-14","current":3.072474,"twenty":-11.617166,"median":2.597676,"eighty":4.019762,"marketCap":267948919},{"date":"2025-03-21","current":3.19042,"twenty":-11.617166,"median":2.602718,"eighty":4.019762,"marketCap":278234866},{"date":"2025-03-28","current":3.143241,"twenty":-11.617166,"median":2.604735,"eighty":4.019762,"marketCap":274120487},{"date":"2025-04-04","current":3.008068,"twenty":-11.617166,"median":2.604735,"eighty":4.019762,"marketCap":262332100},{"date":"2025-04-11","current":2.734909,"twenty":-11.610741,"median":2.605743,"eighty":4.017423,"marketCap":238510000},{"date":"2025-04-17","current":2.844071,"twenty":-11.610741,"median":2.605743,"eighty":4.017423,"marketCap":248030000},{"date":"2025-04-25","current":2.941538,"twenty":-11.617166,"median":2.604735,"eighty":4.019762,"marketCap":256530000},{"date":"2025-05-02","current":2.982474,"twenty":-11.617166,"median":2.604735,"eighty":4.019762,"marketCap":260100000},{"date":"2025-05-09","current":2.966879,"twenty":-11.617166,"median":2.604735,"eighty":4.019762,"marketCap":258740000},{"date":"2025-05-16","current":3.07994,"twenty":-11.617166,"median":2.604735,"eighty":4.019762,"marketCap":268600000},{"date":"2025-05-23","current":3.048751,"twenty":-11.617166,"median":2.604735,"eighty":4.019762,"marketCap":265880000},{"date":"2025-05-30","current":3.081889,"twenty":-11.617166,"median":2.604735,"eighty":4.005123,"marketCap":268770000},{"date":"2025-06-06","current":3.280721,"twenty":-11.617166,"median":2.604735,"eighty":3.951408,"marketCap":286110000},{"date":"2025-06-13","current":3.035105,"twenty":-11.617166,"median":2.604735,"eighty":3.905283,"marketCap":264690000},{"date":"2025-06-20","current":3.084001,"twenty":-11.623592,"median":2.603727,"eighty":3.88837,"marketCap":268954204},{"date":"2025-06-27","current":3.062339,"twenty":-11.623592,"median":2.603727,"eighty":3.873763,"marketCap":267064998},{"date":"2025-07-03","current":3.145051,"twenty":-11.623592,"median":2.603727,"eighty":3.866076,"marketCap":274278330}],"updateTime":1751962444255}}}